A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities
收藏DataCite Commons2025-07-07 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005076/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to see whether subjects with gout who receive febuxostat or allopurinol for up to 9 years have a higher rate of serious heart and blood vessel complications (major cardiovascular events).
提供机构：
Vivli
创建时间：
2019-12-05
